The US travel state department has released its first visa bulletin for 2026, with all eyes on categories moving ahead for Indian visa applicants. January 2026 visa bulletin keeps India’s green card ...

US President Donald Trump introduced a $1 million ‘Gold Card’ designed to provide immigrants a route to US citizenship. This card enables wealthy foreign nationals to get permanent residency by ...

Do you know that the United States remains one of the most attractive destinations for global investors, entrepreneurs and high-skilled professionals seeking long-term residency. There are two ...

WASHINGTON — President Donald Trump announced Wednesday that his long-promised “gold card” was officially going on sale, offering legal status and an eventual pathway to U.S. citizenship for ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

More than 500 fans reportedly lined up to be part of EB Game’s Pokémon Pop-up event at Toronto’s Eaton Centre mall, but don’t worry if you missed out, it’s still running until January 15. Coming up ...

EB Games is opening a temporary location in the Toronto Eaton Centre and will focus on Pokémon-themed content from November 1 to 15. In an email, the company called the store ‘Collector’s Vault’, and ...

Become a Vogue Business Member to receive unlimited access to Member-only reporting and insights, our Beauty and TikTok Trend Trackers, Member-only newsletters and exclusive event invitations. It’s ...

The U.S. State Department has announced that all available Employment-Based Second Preference (EB-2) visas for the Fiscal Year (FY) 2025 have been issued, temporarily pausing green card processing in ...

ROOTSTOWN, Ohio--(BUSINESS WIRE)--#BioMendics--BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a ...

BioMendics, a clinical-stage biopharmaceutical company focused on rare skin diseases, today announced the launch of the TAMES-02 clinical trial—a multicenter, randomized, double-blind, ...